XI International Conference on Human Retrovirology: HTLV

描述(申请人提供)：HTLV-I和HTLV-II是在艾滋病毒之前发现的人类逆转录病毒。它们之所以重要，是因为它们1)感染全球多达1,400万人(HTLV-I)和数百万人(HTLV-II)；2)导致血液、神经和自身免疫性疾病(HTLV-I)和神经系统疾病，并增加对细菌感染的易感性(HTLV-II)；以及3)作为艾滋病毒等其他人类逆转录病毒感染的流行病学和发病机制的模型。国际人类逆转录病毒学会议：HTLV和相关病毒是两年一次的会议，旨在将全球HTLV研究人员团结在唯一专门讨论HTLV感染的定期国际会议上。来自HTLV流行地区和国际传染病研究机构的300至350名学者齐聚这一两年一度的会议，介绍他们关于HTLV感染的分子病毒学、免疫学、流行病学和临床结果的最新数据。从历史上看，会议曾在夏威夷、牙买加、特立尼达、巴西和日本东南部等HTLV流行地区或巴黎和都柏林等国际研究中心举行。计划在旧金山举行的2002年会议将是自1994年以来的第一次美国会议，组织者计划强调与旧金山和美国有关的研究主题，即与注射毒品使用有关的HTLV-II和输血传播病毒感染。旧金山会场将允许更多的美国初级科学家和学生参加，因为国内旅行成本较低，实现了我们鼓励新一代HTLV研究人员的目标。为了鼓励来自地方性HTLV感染的发展中国家的与会者继续大力参与，这项赠款申请旨在支付会议费用并使注册费保持在负担得起的水平。 在旧金山举行的第十一届人类逆转录病毒学会议：HTLV和相关病毒的目标是： 为介绍与HTLV-I、HTLV-II以及相关的人类和灵长类病毒有关的原创研究提供论坛； 促进基础科学家、流行病学家和临床研究人员之间的跨学科互动，以促进“床到床”研究； 促进发达国家和发展中国家科学家之间的互动，并促进国际合作； 让学生和年轻科学家接触HTLV研究领域，促进他们的研究事业。

DESCRIPTION (provided by applicant): HTLV-I and HTLV-II are human retroviruses discovered just prior to HIV. They are important because they 1) infect up to 14 million (HTLV-I) and several million (HTLV-II) people worldwide; 2) cause hematologic, neurologic and autoimmune disease (HTLV-I) and neurologic disease together with increased susceptibility to bacterial infections (HTLV-II); and 3) serve as models for the epidemiology and pathogenesis of other human retroviral infections such as HIV. The International Conference on Human Retrovirology: HTLV and Related Viruses is a biennial conference which serves to unite the global community of HTLV researchers at the only regular international meeting devoted exclusively to HTLV infection. Three hundred to 350 scholars from HTLV-endemic regions and international infectious disease research institutions gather at this biennial meeting to present their latest data on the molecular virology, immunology, epidemiology and clinical outcomes of HTLV infection. Historically the meeting has been held in HTLV-endemic areas such as Hawaii, Jamaica, Trinidad, Brazil, and southeastern Japan, or at international research centers such as Paris and Dublin. The 2002 meeting planned for San Francisco will be the first USA meeting since 1994, and the organizers plan to emphasize research themes relevant to San Francisco and the USA, namely injection drug use-related HTLV-II and transfusion transmission viral infections. The San Francisco venue will allow more US junior scientists and students to attend due to lower domestic travel costs, fulfilling our goal of encouraging a new generation of HTLV researchers. In order to encourage the continued strong participation of attendees from developing countries with endemic HTLV infection, this grant application seeks to defray meeting expenses and keep registration fees affordable. The objectives for the XI Conference on Human Retrovirology: HTLV and related Viruses in San Francisco are: To provide a forum for the presentation of original research pertaining to HTLV-I, HTLV-II and related human and primate viruses; To promote interdisciplinary interaction between basic scientists, epidemiologists and clinical researchers toward fostering "bench to bedside" research; To promote interaction between scientists in the developed and developing world, and to stimulate international collaboration; and To expose students and young scientists to the HTLV research arena and promote their research careers.